胎児の成熟のための産前コルチコステロイド:主要なガイドラインの包括的なレビュー
Sonia Giouleka1, Lampriana Grigoropoulou, Georgios Michos
1Third Department of Obstetrics and Gynaecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Obstetrical & gynecological survey
|February 19, 2026
まとめ
産前コルチコステロイド (ACS) は,早産児のアウトカムを改善します. ガイドラインは一般的にACSの使用について合意しているが,推奨は特定の状態によって異なるため,利益を最大化し,リスクを最小限に抑えるためにより明確なガイドラインが必要である.
科学分野:
- 妊産婦・胎児医学について
- 新生児のアウトカムについて
- 証拠に基づいた実践
背景:
- 胎児前コルチコステロイド (ACS) は,胎児の肺の成熟度を高め,早産前の新生児合併症を軽減するために不可欠です.
- 確立されたガイドラインは,予期される早産におけるACS投与の推奨事項を提供します.
研究 の 目的:
- 産前コルチコステロイド (ACS) 使用に関する最新の影響力のある国際ガイドラインの比較レビューを実施する.
- 現在のACS勧告におけるコンセンサスと相違の領域を特定する.
主な方法:
- 主要な国際産婦人科および産周医学学会からのガイドラインの比較分析が行われました.
- 主要な協会には,ACOG,RCOG,FIGO,EAPM,WAPM,WHO,SOGC,RANZCOGなどがある.
主要な成果:
- 妊娠24+0~33+6週間のACSの普遍的な推薦は,生育可能な段階で考慮して,予期される早産を想定するものです.
- PROM,肥満,多胎妊娠,FGR,糖尿病などの併発性疾患の治療法および使用に関する広範な合意が存在する.
- 遅い早産,コリオアムニオニトス,再発性/持続的な早産の脅威,計画された帝王切開 (RCOGのみは38+6週に及ぶ) については,異なる勧告が指摘されています.
結論:
- コルチコステロイドは,早産の新生児のアウトカムを大幅に改善します.
- 異なる妊娠段階と出産状況における利益と害の詳細な解明が必要である.
- 一貫した勧告の開発は,ACSの恩恵を最適化し,リスクを軽減するために極めて重要です.
関連する概念動画
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
1.2K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
1.2K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.6K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.6K
01:07Teratogenicity
4.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
888
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
888
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
546
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
546
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.3K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.3K